Suggestions

Du même auteur

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Archive ouverte | Mazieres, J. | CCSD

International audience. Anti-PD1/PD-L1 directed immune checkpoint inhibitors (ICI) are widely used to treat patients with advanced non-small-cell lung cancer (NSCLC). The activity of ICI across NSCLC harboring oncog...

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic

Archive ouverte | Girard, N. | CCSD

International audience

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

Archive ouverte | Molinier, O. | CCSD

International audience. Background: Immunotherapy using inhibitors targeting immune checkpoint programmed cell death protein 1 (PD-1)/ programmed death-ligand 1 (PD-L1) is currently the standard of care in patients ...

Chargement des enrichissements...